316 related articles for article (PubMed ID: 18051966)
1. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
[No Abstract] [Full Text] [Related]
2. [LMWH and UFH in direct comparison. Consent: CERTIFY].
MMW Fortschr Med; 2007 May; 149(20):53. PubMed ID: 18051967
[No Abstract] [Full Text] [Related]
3. Prevention of venous thromboembolism among hospitalized medical patients.
Goldhaber SZ; Turpie AG
Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
[No Abstract] [Full Text] [Related]
4. [Prevention and treatment of venous thromboembolism in patients with cancer].
Struve S; Wendtner CM
Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
[No Abstract] [Full Text] [Related]
5. [Deep venous thrombosis--treatment].
Fries R; Böhm M
Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
[No Abstract] [Full Text] [Related]
6. Management of thrombosis during pregnancy.
Inbal A
Isr Med Assoc J; 2002 Oct; 4(10):813-4. PubMed ID: 12389348
[No Abstract] [Full Text] [Related]
7. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
8. When can the patient with deep venous thrombosis begin to ambulate?
Aldrich D; Hunt DP
Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
[No Abstract] [Full Text] [Related]
9. [Thromboembolisms endanger the internist patients, too: who needs heparin].
Bischoff A
MMW Fortschr Med; 2006 Mar; 148(11):21-2. PubMed ID: 16612959
[No Abstract] [Full Text] [Related]
10. [Indications and clinical application of thrombosis prophylaxis. I].
Mittelkötter U; Reith HB; Thiede A
Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
[No Abstract] [Full Text] [Related]
11. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
Bergqvist D
Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
[No Abstract] [Full Text] [Related]
12. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparins: beyond thrombosis in the management of the cancer patient.
Kakkar AK
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():13-5. PubMed ID: 14730473
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of venous thrombosis and pulmonary artery thromboembolism in non-surgical patients: specification of indications].
Iavelov IS
Ter Arkh; 2007; 79(9):70-9. PubMed ID: 18038592
[No Abstract] [Full Text] [Related]
15. Thromboprophylaxis and death after total hip replacement.
Warwick D
J Bone Joint Surg Br; 1998 Mar; 80(2):370-1. PubMed ID: 9546479
[No Abstract] [Full Text] [Related]
16. Guideline update. VTE disease: which agents, and when.
Holten KB; Merok J
J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
[No Abstract] [Full Text] [Related]
17. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
Wille-Jorgensen P
Br J Surg; 2006 Mar; 93(3):374; author reply 375-6. PubMed ID: 16498577
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
19. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
Agnelli G; Bergqvist D; Dahl O; Eriksson B; Rud Lassen M; Mouret P; Rosencher N
Br J Surg; 2006 Mar; 93(3):375; author reply 375-6. PubMed ID: 16498579
[No Abstract] [Full Text] [Related]
20. Letter 2: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
Tangelder MJ; Bylock A; Held P
Br J Surg; 2006 Mar; 93(3):374-5; author reply 375-6. PubMed ID: 16498578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
